AbbVie | ABBV - Ebit





Ebit Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
Abbott USD 2.13B 281M 2026-06
ALKERMES USD -65.93M 17.65M 2026-06
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 3.16B 3.95B 2026-06
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eisai JPY 24.73B 35.04B 2026-06
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
J&J USD 7.48B 860M 2026-06
Medtronic USD 2.09B 354M 2026-03
Merck USD -1.88B 8.12B 2026-03
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD -180M 5.16B 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.12B 811M 2026-06
UCB EUR 1.29B 571M 2025-12
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06
Zoetis USD 842M 7M 2026-03